AlzeCure Pharma AB Statistics
AlzeCure Pharma AB (AC6) Stock Statistics & Valuation Metrics
Total Valuation
AlzeCure Pharma AB has a market cap or net worth of EUR 79.47M. The enterprise value is EUR 849.11M.
- Market Cap
- EUR 79.47M
- Enterprise Value
- EUR 849.11M
Share Statistics
AlzeCure Pharma AB has 137,897,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 137,897,340
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
AlzeCure Pharma AB’s return on equity (ROE) is -1.45 and return on invested capital (ROIC) is -139.15%.
- Return on Equity (ROE)
- -1.45
- Return on Assets (ROA)
- -0.81
- Return on Invested Capital (ROIC)
- -139.15%
- Return on Capital Employed (ROCE)
- -1.39
- Revenue Per Employee
- 0
- Profits Per Employee
- -4.77M
- Employee Count
- 10
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of AlzeCure Pharma AB is 10.67. AlzeCure Pharma AB’s PEG ratio is 0.02.
- PE Ratio
- 10.67
- PS Ratio
- 5.40
- PB Ratio
- 4.23
- Price to FCF
- 8.57
- Price to Operating Cash Flow
- 8.99
- PEG Ratio
- 0.02
Income Statement
In the last 12 months, AlzeCure Pharma AB had revenue of 0 and earned -47.65M in profits. Earnings per share was -0.47.
- Revenue
- 0
- Gross Profit
- -1.27M
- Operating Income
- -49.37M
- Pretax Income
- -47.67M
- Net Income
- -47.65M
- EBITDA
- -48.10M
- Earnings Per Share (EPS)
- -0.47
Cash Flow
In the last 12 months, operating cash flow was 110.55M and capital expenditures 0, giving a free cash flow of 110.55M billion.
- Operating Cash Flow
- 110.55M
- Free Cash Flow
- 110.55M
- Free Cash Flow per Share
- 0.71
Dividends & Yields
AlzeCure Pharma AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 11.66%
- Earnings Yield
- 10.06%
Stock Price Statistics
- Beta
- -0.37
- 52-Week Price Change
- 335.77%
- 50-Day Moving Average
- 0.60
- 200-Day Moving Average
- 0.36
- Relative Strength Index (RSI)
- 46.15
- Average Volume (3m)
- 1,354
Important Dates
AlzeCure Pharma AB upcoming earnings date is Feb 23, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Nov 11, 2026
- Next Earnings Date
- Feb 23, 2027
- Ex-Dividend Date
- ―
Financial Position
AlzeCure Pharma AB as a current ratio of 2.33, with Debt / Equity ratio of 15.55%
- Current Ratio
- 2.33
- Quick Ratio
- 2.33
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 0.94
- Interest Coverage Ratio
- -180.85
Taxes
In the past 12 months, AlzeCure Pharma AB has paid 18.00K in taxes.
- Income Tax
- 18.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
AlzeCure Pharma AB EV to EBITDA ratio is 7.32, with an EV/FCF ratio of 6.34.
- EV to Sales
- 3.99
- EV to EBITDA
- 7.32
- EV to Free Cash Flow
- 6.34
- EV to Operating Cash Flow
- 6.34
Balance Sheet
AlzeCure Pharma AB has EUR 231.93M in cash and marketable securities with EUR 1.72M in debt, giving a net cash position of EUR 230.22M billion.
- Cash & Marketable Securities
- EUR 231.93M
- Total Debt
- EUR 1.72M
- Net Cash
- EUR 230.22M
- Net Cash Per Share
- EUR 1.67
- Tangible Book Value Per Share
- EUR 1.51
Margins
Gross margin is 59.15%, with operating margin of 53.77%, and net profit margin of 56.88%.
- Gross Margin
- 59.15%
- Operating Margin
- 53.77%
- Pretax Margin
- 56.88%
- Net Profit Margin
- 56.88%
- EBITDA Margin
- 54.51%
- EBIT Margin
- 53.77%

